Twist Bioscience (TWST) Total Current Liabilities (2018 - 2026)

Twist Bioscience has reported Total Current Liabilities over the past 9 years, most recently at $120.0 million for Q1 2026.

  • Quarterly Total Current Liabilities rose 60.02% to $120.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $120.0 million through Mar 2026, up 60.02% year-over-year, with the annual reading at $91.4 million for FY2025, 28.73% up from the prior year.
  • Total Current Liabilities was $120.0 million for Q1 2026 at Twist Bioscience, up from $80.4 million in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $120.0 million in Q1 2026 and troughed at $65.2 million in Q4 2023.
  • The 5-year median for Total Current Liabilities is $75.0 million (2025), against an average of $80.7 million.
  • Year-over-year, Total Current Liabilities soared 109.27% in 2022 and then decreased 22.2% in 2023.
  • A 5-year view of Total Current Liabilities shows it stood at $83.8 million in 2022, then fell by 22.2% to $65.2 million in 2023, then grew by 6.77% to $69.6 million in 2024, then increased by 15.5% to $80.4 million in 2025, then surged by 49.15% to $120.0 million in 2026.
  • Per Business Quant, the three most recent readings for TWST's Total Current Liabilities are $120.0 million (Q1 2026), $80.4 million (Q4 2025), and $91.4 million (Q3 2025).